Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2015

Open Access 01-05-2015 | Glycogenoses

Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients

Authors: Pierre G. Carlier, Noura Azzabou, Paulo Loureiro de Sousa, Arnaud Hicks, Jean-Marc Boisserie, Alexis Amadon, Robert-Yves Carlier, Claire Wary, David Orlikowski, Pascal Laforêt

Published in: Journal of Inherited Metabolic Disease | Issue 3/2015

Login to get access

Abstract

Adult late-onset Pompe disease is most often a slowly progressive limb-girdle and spine extensor muscle dystrophy, due to defective lysosomal acid maltase. With the exception of the few patients who present with a dramatically accelerated clinical course, standard diagnostic imaging fail to detect and evaluate disease progression between two successive visits. In muscle dystrophy of very rapid evolution, like the Duchenne disease, quantitative NMR imaging has successfully demonstrated its capacity to objectivate both disease activity and degenerative changes progression over short follow-up periods. The purpose of this retrospective monocentric open-label study was to investigate whether quantitative NMR imaging can monitor disease progression in adult Pompe patients despite its very slow nature. Quantitative imaging of Pompe patients succeeded in demonstrating that muscle fatty infiltration increased on average by 0.9 %/year, with the hamstring and adductor muscles showing the fastest degradation. Muscle water T2 mapping revealed that 32 % of all muscles had abnormally high T2 in at least one of two successive examinations. When muscle water T2 was abnormal, fatty degenerative changes were further increased by 0.61 %/year. Enzyme replacement therapy resulted in 0.68 %/year slowdown of the muscle fatty infiltration, in both muscles with normal and high T2s.
Appendix
Available only for authorised users
Literature
go back to reference Arpan I, Forbes SC, Lott DJ et al (2013) T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed 26:320–328CrossRefPubMedCentralPubMed Arpan I, Forbes SC, Lott DJ et al (2013) T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed 26:320–328CrossRefPubMedCentralPubMed
go back to reference Azzabou N, Loureiro de Sousa P, Caldas E, Carlier PG (2014) Validation of a generic approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle. J Magn Reson Imaging Azzabou N, Loureiro de Sousa P, Caldas E, Carlier PG (2014) Validation of a generic approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle. J Magn Reson Imaging
go back to reference Carlier PG (2014) Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications. Neuromuscul Disord 24:390–392CrossRefPubMed Carlier PG (2014) Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications. Neuromuscul Disord 24:390–392CrossRefPubMed
go back to reference Carlier PG, Azzabou N, de Sousa PL et al (2013) P.14.4 Diagnostic role of quantitative NMR imaging exemplified by 3 cases of juvenile dermatomyositis. Neuromuscul Disord 23:814CrossRef Carlier PG, Azzabou N, de Sousa PL et al (2013) P.14.4 Diagnostic role of quantitative NMR imaging exemplified by 3 cases of juvenile dermatomyositis. Neuromuscul Disord 23:814CrossRef
go back to reference de Kerviler E, Leroy-Willig A, Jehenson P et al (1991) Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology 181(1):259–264CrossRefPubMed de Kerviler E, Leroy-Willig A, Jehenson P et al (1991) Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology 181(1):259–264CrossRefPubMed
go back to reference Friedman SD, Poliachik SL, Otto RK et al (2013) Longitudinal features of stir bright signal in FSHD(1.). Muscle Nerve Friedman SD, Poliachik SL, Otto RK et al (2013) Longitudinal features of stir bright signal in FSHD(1.). Muscle Nerve
go back to reference Glover GH, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 18:371–383CrossRefPubMed Glover GH, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 18:371–383CrossRefPubMed
go back to reference Güngör D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 8:49–56CrossRefPubMedCentralPubMed Güngör D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 8:49–56CrossRefPubMedCentralPubMed
go back to reference Hollingsworth KG, de Sousa PL, Straub V, Carlier PG (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris. France Neuromuscul Disord 22(Suppl 2):S54–S67CrossRef Hollingsworth KG, de Sousa PL, Straub V, Carlier PG (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris. France Neuromuscul Disord 22(Suppl 2):S54–S67CrossRef
go back to reference Hu HH, Börnert P, Hernando D et al (2012) ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med 68:378–388CrossRefPubMedCentralPubMed Hu HH, Börnert P, Hernando D et al (2012) ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med 68:378–388CrossRefPubMedCentralPubMed
go back to reference Jehenson P, Duboc D, Bloch G et al (1991) Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy. Neuromuscul Disord 1(2):99–101CrossRefPubMed Jehenson P, Duboc D, Bloch G et al (1991) Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy. Neuromuscul Disord 1(2):99–101CrossRefPubMed
go back to reference Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950CrossRefPubMed Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950CrossRefPubMed
go back to reference Ravaglia S, Pichiecchio A, Ponzio M et al (2010) Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. J Inherit Metab Dis 33:737–745CrossRefPubMed Ravaglia S, Pichiecchio A, Ponzio M et al (2010) Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. J Inherit Metab Dis 33:737–745CrossRefPubMed
go back to reference Saab G, Thompson RT, Marsh GD (2000) Effects of exercise on muscle transverse relaxation determined by MR imaging and in vivo relaxometry. J Appl Physiol 88:226–233PubMed Saab G, Thompson RT, Marsh GD (2000) Effects of exercise on muscle transverse relaxation determined by MR imaging and in vivo relaxometry. J Appl Physiol 88:226–233PubMed
go back to reference Tardif-de Géry S, Vilquin J, Carlier P et al (2000) Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy(2j)/dy(2j) mice. Neuromuscul Disord 10:507–513CrossRefPubMed Tardif-de Géry S, Vilquin J, Carlier P et al (2000) Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy(2j)/dy(2j) mice. Neuromuscul Disord 10:507–513CrossRefPubMed
go back to reference Thibaud J-L, Monnet A, Bertoldi D et al (2007) Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 17:575–584CrossRefPubMed Thibaud J-L, Monnet A, Bertoldi D et al (2007) Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 17:575–584CrossRefPubMed
go back to reference Thurberg BL, Lynch Maloney C, Vaccaro C et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86:1208–1220CrossRefPubMed Thurberg BL, Lynch Maloney C, Vaccaro C et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86:1208–1220CrossRefPubMed
go back to reference Tofts PS (2003) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New York Tofts PS (2003) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New York
go back to reference Walter G, Cordier L, Bloy D, Sweeney HL (2005) Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54:1369–1376CrossRefPubMed Walter G, Cordier L, Bloy D, Sweeney HL (2005) Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54:1369–1376CrossRefPubMed
go back to reference Willcocks RJ, Arpan IA, Forbes SC et al (2014) Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord 24:393–401CrossRefPubMedCentralPubMed Willcocks RJ, Arpan IA, Forbes SC et al (2014) Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord 24:393–401CrossRefPubMedCentralPubMed
go back to reference Willis TA, Hollingsworth KG, Coombs A et al (2013) Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS One 8:e70993CrossRefPubMedCentralPubMed Willis TA, Hollingsworth KG, Coombs A et al (2013) Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS One 8:e70993CrossRefPubMedCentralPubMed
go back to reference Yarnykh VL (2007) Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med 57:192–200CrossRefPubMed Yarnykh VL (2007) Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med 57:192–200CrossRefPubMed
Metadata
Title
Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients
Authors
Pierre G. Carlier
Noura Azzabou
Paulo Loureiro de Sousa
Arnaud Hicks
Jean-Marc Boisserie
Alexis Amadon
Robert-Yves Carlier
Claire Wary
David Orlikowski
Pascal Laforêt
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9825-9

Other articles of this Issue 3/2015

Journal of Inherited Metabolic Disease 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.